The clinical applicability of polygenic risk scores for LDL-cholesterol: considerations, current evidence and future perspectives
Authors:
Open Access
- 4 February 2021
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Lipidology
- Vol. 32 (2) , 112-116
Abstract
Purpose of review: The current review describes the development, clinical relevance and potential caveats of polygenic risk scores (PRS) for LDL cholesterol (LDL-C). Recent findings: In recent years, a large number of common variants have been shown to have a small effect on LDL-C levels. The aggregate effect of all of these variants on LDL-C levels can be captured in a PRS and an elevated number of LDL-C increasing common variants is considered to be a cause of high LDL-C levels in patients with familial hypercholesterolemia (FH) without a large effect, rare mutation. PRS do not only serve as a tool in diagnostics, but are also helpful in cardiovascular disease (CVD) risk prediction. Moreover, PRS modulate CVD risk even in patients without a monogenic FH. However, future larger scale PRS directly aimed at CVD risk may serve as more sensitive tools to identify individuals with severely increased CVD risk. Summary: LDL-C PRS help explain part of hypercholesterolemia in a proportion of dyslipidemic patients that do not have monogenic FH. Nevertheless, the CVD risk conferred by current PRS does not appear to match that of monogenic FH. LDL-C PRS are currently not widely used in clinical care.Keywords
This publication has 30 references indexed in Scilit:
- Polygenic Versus Monogenic Causes of Hypercholesterolemia Ascertained ClinicallyArteriosclerosis, Thrombosis, and Vascular Biology, 2016
- Diagnostic Yield and Clinical Utility of Sequencing Familial Hypercholesterolemia Genes in Patients With Severe HypercholesterolemiaJACC, 2016
- Incorporating a Genetic Risk Score Into Coronary Heart Disease Risk EstimatesCirculation, 2016
- Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatmentEuropean Heart Journal, 2015
- An Examination of the Relationship between Lipid Levels and Associated Genetic Markers across Racial/Ethnic Populations in the Multi-Ethnic Study of AtherosclerosisPLOS ONE, 2015
- Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis SocietyEuropean Heart Journal, 2013
- Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: a case-control studyThe Lancet, 2013
- The LDL ReceptorArteriosclerosis, Thrombosis, and Vascular Biology, 2009
- Common variants at 30 loci contribute to polygenic dyslipidemiaNature Genetics, 2008
- Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humansNature Genetics, 2008